Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SentreHEART logo — Achieving seamless soft tissue closure with innovative remot...

SentreHEART

Achieving seamless soft tissue closure with innovative remote suture technology, without leaving any metal, clips, or fabrics behind.

Founded 2005 Series D Total: $69.02M Health Care, Medical Devices

General Information

Company Name SentreHEART
Founded Year 2005
Industries Health Care, Medical Devices
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with SentreHEART. To contact SentreHEART, visit sentreheart.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SentreHEART

SentreHEART, Inc. is a medical device company based in Redwood City, California, established in 2005. The company specializes in producing the LARIAT Suture Delivery Device, which utilizes innovative remote suture technology for seamless soft tissue closure. This technology enables the remote deployment of a 40mm pre-tied suture loop through an access point as small as 4.3mm, without leaving any metal, clips, or fabrics behind. SentreHEART has obtained regulatory approval for soft tissue ligation and approximation in the US, Europe, and Canada. Notably, SentreHEART received a significant $35.00M Series D investment on September 27, 2016. The investors involved in this round were Prospect Venture Partners, US Venture Partners, Vivo Capital, Decheng Capital, and Deerfield. This investment further reflects the confidence and support the company has garnered from prominent venture capital firms, highlighting the potential and promising future of SentreHEART in the Health Care and Medical Devices industries.

Taxonomy: suture technology, soft tissue closure, catheter technology, suture delivery, medical innovation, Regulatory approvals, minimal access surgery, bio-medical engineering, innovative medical devices

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $35.00M 5
Prospect Venture Partners US Venture Partners Vivo Capital
Prospect Venture Partners, US Venture Partners +3
27 Sep 2016
Series C $26.00M 3
Prospect Venture Partners US Venture Partners Vivo Capital
Prospect Venture Partners, US Venture Partners +1
04 Jun 2012
Series B $5.99M -
16 Jan 2007
Series A $2.03M -
17 Aug 2005

SentreHEART Alternatives & Competitors

View All Alternatives
SentreHEART vs
Angiolink Corporation
Angiolink Corporation

Experience precision in arterial closure with advanced vascular stapling solutions.

Series B
Biotechnology, Health Care
SentreHEART vs
CoNextions Medical
CoNextions Medical United States

Revolutionizing Tendon Repair

Venture round
17 employees
Health Care, Health and Wellness
SentreHEART vs
Pi-Cardia
Pi-Cardia Israel

Leading the way for leaflet modification

Debt Financing
59 employees
Health Care, Medical Devices
View all alternatives

FAQ About SentreHEART

Achieving seamless soft tissue closure with innovative remote suture technology, without leaving any metal, clips, or fabrics behind.
SentreHEART was founded in 2005.
SentreHEART operates in Health Care and Medical Devices. Its work centres on suture technology, soft tissue closure, catheter technology and suture delivery.
SentreHEART has completed 4 funding rounds, raising a total of $69.02M. The latest funding stage is Series D.
Top alternatives and competitors to SentreHEART include Angiolink Corporation, CoNextions Medical, Pi-Cardia, VESTECK, Inc, Virtual Ports Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SentreHEART and Angiolink Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SentreHEART, https://bouncewatch.com/company/sentreheart, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes